Invivyd data shows strong potency and prolonged antibody levels in trials. Q4 Pemgarda revenue rose 48% to $13.8 million.

The stock is trading at 1.0150, up 0.6573, gaining 183.7573% on volume of over 422 Million shares, with a day's high of $1.11. The stock announced breaking news on its Monoclonal Antibody designed to ...

The new Mu variant of the novel coronavirus is more than seven times more resistant to antibodies created by vaccinations than the original strain of the virus, a study by a Japanese research team ...

The antibody targets a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and offer long-term protection against the globally spreading airborne infection.

This article explores how broadly neutralizing antibodies are being researched, not only for their potential in the ...

A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.

The following is a summary of “Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain),” published in the January 2025 issue of Infectious Disease by Montagud et al ...

University of Idaho researchers found that the COVID-19 vaccine does not have any adverse effects on a mother’s breast milk.

“Although individual vaccines have been developed and approved for use in humans against SARS-CoV-2 and influenza viruses, ...

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.